Drug recall · February 2, 2022
Proctofoam HC recall
Why: cGMP deficiencies
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Proctofoam HC (hydrocortisone acetate 1% and pramoxine hydrochloride 1%) topical aerosol, 10 g aerosol containers, Rx Only, Distributed by Meda Pharmaceuticals Inc, Somerset, New Jersey 08873-1120, NDC 0037-6822-10.
- Lots / codes
Lot #: 32925, Exp. date May 2023, 33010, Exp. date June 2023; 33119, 33123, Exp. date August 2023
- Quantity
- 233,199/10 g aerosol containers
- Company
- Mylan Pharmaceuticals Inc, Morgantown, WV
- Distribution
- Recalled product was distributed nationwide within the United States.
- Initiated
- January 21, 2022 · Voluntary: Firm initiated
- Classified
- January 25, 2022
- Reported
- February 2, 2022
- Ended
- March 12, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Proctofoam-HC
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.